You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

toripalimab

Showing 1 - 25 of 139
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

Recruiting
  • Esophageal Carcinoma
  • toripalimab
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 20, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Solid Tumor Trial in Changchun (WX390, Toripalimab)

Recruiting
  • Solid Tumor
  • Changchun, Jilin, China
    the first affiliated hospital of Jilin university
Nov 3, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

Recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Oct 16, 2023

NSCLC Trial in Shanghai (Toripalimab, Cryoablation)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Toripalimab
  • Cryoablation
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 7, 2023

Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

Recruiting
  • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
  • Shanghai, Shanghai, China
    The Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Toripalimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 2, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • Toripalimab
  • +3 more
  • (no location specified)
Aug 16, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Toripalimab
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • (no location specified)
Jul 12, 2023

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • Toripalimab
  • Radical thoracic radiotherapy
  • (no location specified)
Jun 2, 2023

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

Rectal Cancer Trial in Chengdu (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Mar 8, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Toripalimab
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 1, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 7, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Toripalimab
  • (no location specified)
Mar 20, 2023

Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

Recruiting
  • Lung Cancer
  • Toripalimab
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Dec 7, 2022

Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Toripalimab
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023

Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

Not yet recruiting
  • Breast Neoplasms
  • Disitamab Vedotin
  • Toripalimab
  • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
  • +2 more
Oct 23, 2023